Insider Buying: Ondine Biomedical Inc. (LON:OBI) Insider Acquires 200,775 Shares of Stock

Ondine Biomedical Inc. (LON:OBI) insider Carolyn Cross purchased 200,775 shares of the stock in a transaction dated Thursday, January 30th. The shares were purchased at an average cost of GBX 12 ($0.15) per share, for a total transaction of £24,093 ($29,921.76).

Ondine Biomedical Price Performance

Shares of OBI stock opened at GBX 12.85 ($0.16) on Friday. The firm’s 50-day moving average is GBX 9.08 and its two-hundred day moving average is GBX 7.95. Ondine Biomedical Inc. has a 12 month low of GBX 4.50 ($0.06) and a 12 month high of GBX 13.30 ($0.17). The company has a debt-to-equity ratio of 1,847.37, a current ratio of 0.80 and a quick ratio of 8.26. The company has a market capitalization of £35.63 million, a PE ratio of -428.33 and a beta of 0.10.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.